The company’s flagship product, RN-501, is a nanoparticle containing approximately 50 million Boron-10 (a stable isotope of boron) atoms per particle. It demonstrates superior accumulation ...
Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has completed the installation of two new cyclotrons at Telix Manufacturing Solutions (TMS) in ...
IMPACT is an upgrade at the proton accelerator facility at PSI, which will be implemented beginning in 2025. IMPACT stands for Isotope and Muon Production with Advanced Cyclotron and Target ...
MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has completed the installation ...